Supplementary Figure S5 from Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells
Abstract
Supplementary Figure S5, related to Figure 4. PARP7i and AHRa response signature is associated with benefit from immune checkpoint blockade.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Nuclear Receptors and Signaling
Endoplasmic Reticulum Stress and Disease
Publication details
- Publication date
- 2 January 2026